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This study examined work-related chronic abnormality in pulmonary function and work-related acute irritant symptoms associated with exposure to
borate dust in mining and processing operations. Chronic effects were examined by pulmonary function at the beginning and end of a 7-year inter-
val. Time-specific estimates of sodium borate particulate exposures were used to estimate cumulative exposure during the study interval. Change
in pulmonary function over the 7 years was found unrelated to the estimate of cumulative exposure during that interval. Exposure-response associ-
ations also were examined with respect to short-term peak exposures and incidence of five symptoms of acute respiratory irritation. Hourly mea-
sures of health outcome and continuous measures of particulate exposure were made on each subject throughout the day. Whenever a subject
reported one of the irritant symptoms, a symptom intensity score was also recorded along with the approximate time of onset. The findings indicat-
ed that exposure-response relationships were present for each of the specific symptoms at several symptom intensity levels. The associations
were present when exposure was estimated by both day-long and short-term (15-min) time-weighted average exposures. Associations persisted
after taking account of smoking, age, and the presence of a common cold. No significant difference in response rate was found between workers
exposed to different types of sodium borate dusts. - Environ Health Perspect 1 02(Suppl 7):119-128 (1994)
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Introduction
In the early 1980s, the California Occupa-
tional Safety and Health Administration
(CalOSHA) adopted the American
Conference of Governmental Industrial
Hygienists' (ACGIH) list of threshold limit
values (TLVs), thereby converting these
from guidelines into legal standards applic-
able in California. Included on the list were
the commercially important forms of sodi-
um tetraborate (Na2B407), the anhydrous
salt, and the pentahydrate and decahydrate
containing 5 and 10 moles of water of
hydration, respectively. The 10-mole salt is
most widely encountered in industry and
in the home, and is generally known as
borax.
Prior to the legislation, the borate TLVs
had been established rather recently by the
ACGIH, and were based upon predicted
irritant effects of boron dust present in
workplace air. In the judgment of the
ACGIH, the anhydrous and 5-mole com-
pounds were most irritating. As a result, a
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TLV of 1 mg/rm3 was established for these,
while the TLV for exposures to the 10-
mole compound was set at 5 mg/ m3.
Prior to the adoption of the TLVs, expo-
sures to all forms of borates in California
were controlled by the same total-dust per-
missible-exposure-limit (PEL) that OSHA
uses elsewhere (10 mg/im3). Since the
newly adopted CalOSHA PELs did not
appear to be consistent with the experience
of U.S. Borax in their production of these
compounds, the company decided to con-
duct the study reported here.
Today, sodium borates are used primarily
in the manufacture of specialized glass,
enamels, and glazes; as soldering and weld-
ing fluxes; as fat solvents; as fixatives for
mordants on textiles; in silk spinning; and
in the soap, leather, and cosmetic indus-
tries. There are an estimated 420,000 U.S.
workers with potential occupational expo-
sure to sodium borates (1).
Prior to the study reported here, there
had been an earlier study that suggested
borate exposure was associated with symp-
toms of acute respiratory irritation, such as
dryness of the mouth, nose, or throat; dry
cough; nose bleeds; sore throat; productive
cough; shortness of breath; and chest tight-
ness (2). Excessive symptoms were reported
at levels estimated between 4 and 14.6
mg/ m3. Symptoms were infrequent at expo-
sures of 1.1 mg/im3. The cross-sectional
design of that earlier study had available
only sparse information on actual exposure,
and had to rely on subjects' recollections of
past irritation. The earlier study also report-
ed a reduction of forced expiratory volume
in 1 sec (FEVI) among smokers who had
heavy cumulative sodium borate exposure
(.80 mg/m3-years), but not among less-
exposed smokers or among nonsmokers.
The present study was designed with the
objective of refining measures of both acute
irritation and current exposure in an effort
to characterize better the acute
exposure-response relationships for sodium
borate particulates. In addition, a longitudi-
nal analysis of pulmonary function related
to chronic exposure was performed. The
study was carried out among U.S. Borax
employees exposed to the various forms of
borate ore and processed materials present at
the Mojave Desert plant site. At this plant,
sodium borate minerals, such as tincal and
kernite, are mined from an open pit. The
resulting ores are processed into refined
borate products and packed for shipment in
bags or railcars. Three major forms of fin-
ished sodium borates are handled in this
environment: disodium tetraborate decahy-
drate-Na2B407 + IOR 20, (10 mole);
disodium tetraborate pentahydrate-
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Na2 B4 07 + 5H20 (5 mole); and disodium
tetraborate-Na2B407, (anhydrous).
The Irritant Response
Many of the irritant symptoms of sodium
borate exposure (sensory irritation of the
nose and throat, cough, phlegm produc-
tion, and bronchoconstriction, as evi-
denced by a decrease in FEVy) are part of
the respiratory defense reflex, which func-
tions to protect the body from inhaled irri-
tants (3). This reflex can be triggered by
agents that stimulate receptors in the respi-
ratory tract (4). However, little is known
about the mechanism by which the irritant
receptors are stimulated.
There is evidence that stimulation of the
irritant reflex response can occur both as a
direct and an indirect response to changes
in the osmolarity of the lung-lining fluid
(5-17) and may be mediated through hist-
amine (18,19). Thus, if hyperosmolarity
triggers defensive reflex responses, the irri-
tant symptoms reported by sodium borate-
exposed workers may be either a direct
function of osmolarity or an indirect func-
tion of histamine.
Methods
Study Design for Chronic Effects
ofExposure
Population and Pulmonary Function
Measures. A prospective (follow-up) cohort
design was used to examine the associations
between change in respiratory health status
during the period 1981 to 1988 and expo-
sure during that same period. This design
relied on the availability of the 1981 survey
results (2). The spirometry instrument
used in 1988 was the Eagle IIS spirometry
system (Warren E. Collins), while that
used in 1981 was an Ohio 840 rolling seal
spirometer. Both meet the American
Thoracic S ociety/ Division of Lung Disease
performance criteria and were found in
side-by-side evaluations to provide the
same results within acceptable spirometer
error. Spirometry results were standardized
using the prediction equations of Knudson
et al. (20). A minimum of five (maximum
of seven) technically acceptable forced expi-
ratory maneuvers were obtained in 1988,
and a minimum of three (maximum of
five) were similarly obtained in 1981. In
both surveys, repeatability was assessed
from the two largest values for each para-
meter. Subjects were tested without regard
to the time of day or day of the work week.
Historical Exposures. Estimates of levels
of dust exposure and the definition of sepa-
rate, homogeneous exposure categories over
time were based on examination of current
exposure measurements, historical records
of exposure, and information on dates of
changes in the introduction of exposure
controls. Since very little exposure informa-
tion existed for the years prior to 1978,
only interim exposures covering the years
between the two surveys were estimated.
This information was then organized in a
matrix that permitted computation of esti-
mates of interim exposure for each subject.
Estimates of cumulative, interim dust
exposure during the 7-year period between
the two surveys were computed as a sum of
the exposure in each job held in the period,
weighted by the number of years between
1981 and 1988 during which the subject
worked in that job.
Study Desig for Acute Effects
ofExposure
In studying the association between sodi-
um borates and acute respiratory irritation,
a primary objective was to describe in detail
the exposure-response relationships
observed when both exposure and response
were measured frequently throughout the
course of daily work activities. A related
question was whether the relationships dis-
covered differed according to the type of
sodium borate exposure. As can be seen,
the borate types varied only by the moles of
waters of hydration in the three chemical
forms.
Population and Health Effects. All
employees were eligible for the acute study
if their exposures to dust could be ade-
quately characterized with respect to borate
type. Subjects eligible for the comparison
group were identified as current nonoffice,
hourly employees who had no routine
exposure to borate particulate (other than
background). A total of 115 exposed and
comparison workers were eligible. All eligi-
bles were invited to participate, and 106
accepted.
At the pre-shift survey, subjects were
queried about the presence of a common
cold on that survey day or within the past
two weeks, about the presence of allergic
symptoms or asthma on the survey day,
and the time of day they last smoked a cig-
arette (see Appendix).
To provide close supervision of the study
protocol, a technician was assigned to each
study subject (2 to 4 subjects were studied
per day) and was instructed to stay with
that subject throughout the day. The tech-
nician was responsible for monitoring the
use of the continuous-exposure monitor,
and for administering the hourly symptom
surveys.
Acute irritant effects were studied in
detail through administration of symptom
questionnaires before work, and at hourly
intervals throughout each of 4 consecutive
workdays (see appendix). The closed-ended
questionnaires were pilot tested on a sepa-
rate group of workers who did not partici-
pate in the full-scale irritant study.
Questionnaires were revised as needed to
confirm that symptom queries were under-
standable. The questionnaire inquired
about symptoms of eye, nose, and throat
irritation; sneezing; nose bleeds; coughing;
and breathlessness. Whenever a subject
reported one of these symptoms, the inter-
viewer requested an intensity score and
approximate time of onset to the nearest
quarter hour. The outcomes were measures
of acute irritant symptoms of the respirato-
ry tract and mucous membranes.
Symptom intensity was scored using a
category-ratio scale based on Borg's studies
of pain or exertion (21-24). A score on a
scale between 0 and 10 was requested
(Figure 1). Subjects were asked to indicate
the time of onset to the nearest 15 min
within the previous hour (or to indicate
when the symptom had persisted from the
previous survey). When the analyses were
restricted to symptoms of a minimum sever-
ity, reports of less severe symptoms were
ignored (i.e., considered nonsymptoms).
Only incident symptoms that arose dur-
ing the workshift were included in the
exposure-response analysis. A symptom
reported at an hourly survey was defined as
an incident symptom if the same type of
symptom was not reported in the preced-
ing hour, or the same type of symptom had
been reported in the preceding interval but
Figure 1. The category ratio severity scale presented
to each study participant at preshift and hourly sur-
veys. When an irritant symptom was reported, the par-
ticipant selected a numerical score to characterize the
severity of the symptom.
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Numerical Severity
value
O Notatall
0.5 Very, very little (just noticeable)
1 Very little
2 Fairly little
3 Moderate
4 Pretty much
5 A lot (strong)
6
7 Very much
8
9
10 Very, very much (almost maximal)
* Maximal
120
ACUTEAND CHRONIC RESPIRATORY EFFECTS OFBORATES
it could be determined that the symptom
had not persisted from one interval to the
next. If no second onset time was reported,
the symptom was regarded as persistent
rather than incident.
In addition to the hourly survey, subjects
were provided a means of adding a mark to
the exposure monitor each time they expe-
rienced an acute irritant symptom (see
"Measurements of Acute Exposures"). This
device permitted each subject to record the
actual time of symptom onset without
technician prompting. However, at the
hourly survey, the technician would ask
whether the marker had been used, and if
so, for what symptom.
Measurements ofAcute Exposures. A per-
sonal direct-reading aerosol monitor (the
MINIRAM, Miniature Real-time Aerosol
Monitor; MIE Inc., formerly GCA,
Bedford, MA) was used in conjunction
with a datalogger system, (the Ranger-
Rustrak; E. Greenwich, RI). This system
provided for the recording of short-inter-
val, real-time exposures.
The MINIRAM aerosol monitor is most
sensitive to aerosols in the respirable size
range, and like all photometers, is sensitive
to high humidity and changes in the parti-
cle-size distribution and composition.
Since irritation of the eyes, nose, and
throat may be caused by particles in the
nonrespirable size range, the MINIRAM's
use in the study had to be calibrated sepa-
rately for the three dust types, as well as for
different particle sizes.
Throughout the study, the MINIRAM
was used in the active mode as a total-dust
monitor, with a flow adapter that enabled
pumps calibrated at 2 / min to pull the
aerosol through the MINIRAM chamber
and onto a closed-faced filter that was sub-
sequently gravimetrically analyzed. To
account for the fact that both borates and
nonspecific dust may have irritant proper-
ties, it was hypothesized that the boron
content of dust samples might better repre-
sent exposure to borates. Consequently,
each filter was also analyzed for total boron
content.
A Marple Personal Cascade Impactor
with four stages (Anderson Samplers;
Atlanta, GA) was used to determine parti-
cle-size distributions with cut points for the
impactor stages at 21.3, 14.8, 9.8, and 3.5
microns (25). A Cahn model 29 elec-
trobalance was used to weigh the filters for
gravimetric determinations. All filters were
desiccated for 18 hr prior to weighing.
Continuous MINIRAM readings were
recorded on a datalogger data tape outfitted
with an event-marker button, so that each
Table 1. Pulmonary function characteristics of follow-up cohort (n= 303).
Category Mean SD Range
FEV,(1981)a 3.95 0.78 1.49-6.02
FEV, (1988) 3.75 0.75 1.23-5.91
% Predicted FEV1 (1988) 96% 14% 46-137%
FVC (1981) 5.14 0.96 2.23-7.91
FVC (1988) 4.95 0.91 2.12-7.92
% Predicted FVC (1988) 104% 13% 67-148%
FEV1 Decline+b 0.20 0.31 -2.02-1.84
FVC Decline+ 0.20 0.38 -2.30-2.39
Abbreviations: FEVJ, forced expiratory volume in 1 sec; FVC, forced vital capacity. a Pulmonary function values
reported in liters. b + decline = test value in 1981-test value in 1988.
subject could mark the time(s) an irritant
symptom occurred. With this sampling
method. it was possible to estimate real-
time, total particulate exposure for each
subject during each survey day. The instru-
ment, however, cannot distinguish the type
of particulate measured. Therefore, sodium
borate type was assigned to each daily
exposure record based on the type of borate
being processed in the area surrounding the
individual's work station.
Data Analysis for Acute Effects. The
exposure-response analysis of symptoms
included detailed examination of exposure
as measured by the MINIRAM-integrated
estimates of daily (6-hr) and short-term
(15-min) exposures. Incidence rates for
each symptom were computed as the ratio
of the number of episodes to the number
of person-hours for which the individual
was at risk. Risk ratios, defined as the ratio
of the probability in the exposed to the
probability in the comparison group, were
estimated for each symptom. Categories of
increasing exposure levels were then
defined, and the incidence was estimated
within each category.
To adjust for confounding due to smok-
ing, age, and recent cold, the associations
were then estimated in a series of logistic
regression models. A separate model was
fitted to the data for each of the five most
common symptom outcomes.
The exposure-response analyses were
based first on daily exposures and then on
exposure measured in 15-min intervals. The
unit of analysis for the daily exposures was
the person-day; and the presence or absence
of a particular symptom over the course of
the day was paired with the daily, measured
exposure. Thus, each person contributed
four observations to these analyses, one for
each person-day of observation.
In the final phase of the symptom analy-
sis, contiguous 15-min intervals were
defined from the start to the end of each
observation day. The presence or absence
of a symptom was then determined for
each interval and paired with the 15-min
exposure for that interval. Probabilities of
response were estimated across categories of
increasing levels. In these stratified analy-
ses, subjects were included up to 96 times,
one for each of the 1 5-min exposure inter-
vals during which they were at risk over
their 4 days of monitoring.
These analyses did not satisfy the
assumption of independent observations,
because multiple observations were made
for each subject. Therefore, methods
recently developed to account for correlat-
ed outcomes in the analysis of repeated
measures were also used. Logistic models
were fit to the data for each individual with
at least three positive symptom reports in
the first stage of a two-stage model. Thus,
each exposure-response model was based
on up to 96 observations. In stage two, the
individual odds ratios were summarized
using a maximum likelihood estimate of
the mean, within strata defined by smok-
ing, cold status, age, and duration of
employment. These results have been pre-
sented in more detail elsewhere (26).
Results
Chronic Pulmonary Function Effects
Loss to Follow-up. Of the 631 workers who
participated in 1981, 371 were available for
the pulmonary-function retesting in 1988.
Of these, 336 performed pulmonary func-
tion tests; 303 of the 336 subjects had
acceptable tests for both years. Those who
were not resurveyed were, on average, 5
years older than those who did participate
in the second survey; they also had smoked
longer than the second survey participants.
FEVI differences between the two groups
appeared to be accounted for by the differ-
ences in smoking.
Follow-up Population. On average, sub-
jects were 44 (± 9.0) years old and had
worked for 19 years; the group included
42% current smokers, 28% ex-smokers,
and 30% never-smokers. The average 1988
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Table 2. FEV, decline by smoking status and years employed.
Years employed
Smoking status 0-10 10-20 >20
Never smoker n= 9 n= 60 n=23
FEV1 decline a 0.24 (0.08) b 0.21 (0.06) 0.17 (0.05)
% pred FEV (1981) 103 (3) c 98 (2) 102 (3)
% pred FEV (1988) 103(2) 97 (1) 102 (2)
>0-10 n=4 n= 12 n=4
FEV1 decline 0.38 (.14) 0.25 (0.06) 0.24 0(.14)
%predFEV,(1981) 104(2) 99(3) 93(6)
% pred FEV1 (1988) 100 (4) 97 (2) 91 (8)
>10-20 n=12 n=28 n=9
FEV1 decline 10 (0.08) 14 (0.05) 0.18 (0.13)
% pred FEV, (1981) 92(3) 104(2) 93(4)
% pred FEV1 (1988) 94 (3) 106 (2) 93 (3)
>20 n=8 n=83 n=40
FEV1 decline 0.16 (0.06) 0.23 (0.04) 0.20 (0.04)
% pred FEV, (1981) 104 (5) 93 (2) 92 (2)
% pred FEV1 (1988) 105 (4) 91 (2) 91 (2)
Abbreviations: FEV,, forced expiratory volume in 1 sec; FVC, forced vital capacity.
a Decline = FEVy (1981) - FEV, (1988). b numbers in parentheses indicate standard error. c Percent predicted based
on Knudson (13).
Table 3. Dose-response model for FEV1 and exposure with adjustments.
Variable 0 SE p>T
Intercept -202 83.7 0.017
Cumulative exposure, 1981-1988 -0.000 0.001 0.999
Years employed to 1981 0.45 1.23 0.717
Pack-years, cigarettes -0.66 0.149 0.001
Age -3.61 0.373 0.001
Height 4.25 0.448 0.001
Table 4. Regression equation relating FVC decline to 1981 to 1988 cumulative exposure with adjustments.
Variable p SEP p>T
Intercept -32.29 58.73 0.5597
FVC, 1981 0.78 0.03 0.0001
Exposure, 1981-88 -0.11 0.24 0.6216
Ever smoked 1.45 4.46 0.7439
Age, 1981 -1.07 0.25 0.0001
Height, cm 0.96 0.39 0.0146
R 2 = .83
Abbreviations: FVC, forced vital capacity; FEVJ, forced expiratory volume in 1 sec.
Table 5. Regression equation relating FEVy decline to 1981 to 1988 cumulative exposure with adjustments.
Variable 0 SEP p>T
Intercept 0.62 43.85 0.9986
FEVi, 1981 0.79 0.03 0.0001
Exposure, 1981-88 -0.07 0.19 0.7122
Ever smoked -2.50 3.59 0.4860
Age, 1981 -0.91 0.22 0.0001
Height, cm 0.56 0.28 0.0450
R2=0.84
Abbreviations: FVC, forced vital capacity; FEV1, forced expiratory volume in 1 sec.
FEVI and forced vital capacity (FVC) val-
ues were 96 and 104% of predicted values,
respectively (Table 1). The average annual
loss in both FEV1 and FVC was close to 30
ml/year, the rate of loss expected on the
basis of cross-sectional studies in most stan-
dard population studies.
Exposure-Response Associations. FEV1
decline and percentage of loss predicted
were examined via duration of work, con-
trolled for smoking status (Table 2).
Although years worked was not associated
with pulmonary status among never-smok-
ers, evidence for an exposure-related
decrease was seen in FEV, percent among
those who had smoked the longest. To
examine these findings further, FEV1 was
regressed on age, height, pack-years of ciga-
rette smoking, and duration of employ-
ment (Table 3). These results suggest that
once cigarette smoking is accounted for,
the effect of exposure duration is not sig-
nificant.
Since exposure measures were not avail-
able prior to the late 1970s, exposure
between 1981 and 1988 was estimated for
each subject. The method and results for
estimating historical exposures are reported
elsewhere (27). These estimates were com-
pared with rates of loss in function over the
study interval. An autoregressive model was
used to examine the exposure-response rela-
tionship, adjusting for the 1981 pulmonary
function level, age, height, and cigarette
smoking status. The models explained 83
and 84% of the variability in the 7-year
decline in FVC and FEV,, respectively
(Tables 4, 5). After taking 1981 FEV1 into
account, current cigarette smoking status
and interim exposure were not statistically
significant factors in predicting FEV1
decline. Nor was duration of employment
prior to 1981 a significant factor.
Acute Irritant ffects
Population. A total of 106 subjects partici-
pated in the survey of acute health effects
of sodium borate exposure. Among the
106, the comparison group was, on aver-
age, 7 years older and included more cur-
rent smokers and workers with longer
employment tenure than the exposed
group (Table 6).
Exposure: Calibration Study. As noted
above, since the MINIRAM cannot sepa-
rately monitor the different sodium borate
aerosols (10 mole borax, 5 mole borax,
and anhydrous borax), the calibration
study had to be carried out in areas where
each of the types was exclusively processed.
Over 450 samples were collected in the
three dust-type environments. The
Environmental Health Perspectives122
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Table 6. Demographic characteristics of 106 borax employees in acute study cohort.
Characteristic a Exposed (79) Comparison (27)
Age 34.0 (7.8) 40.9 (11.1)
Height 69.5 (2.6) 70.3 (3.1)
Sex (male) 78 98.7% 25 92.6%
Race (white) 75 94.9% 26 96.3%
Current smokers 29 36.7% 14 50.0%
Packyears smoking b 9.2 (13.8) 14.0 (20.4)
Duration of employment 8.7 (6.3) 11.9 (7.5)
Physical exertion 10.4 (2.5) 8.5 (2.3)
a Values are expressed as mean ± SD, or as number and percent. b Results are based on 96 subjects (70 exposed
and 26 comparison) whose smoking information was complete from the baseline survey.
samples represented dust concentrations
ranging from 0.1 to 205 mg/im3. The types
of sodium borate dust do not vary greatly in
refractive index or particle size.
Nevertheless, the calibration curves were
examined for each of the dust types and
combinations of dust types to which work-
ers were exposed, to verify that the calibra-
tion did not change across dust types.
Details of the calibration study are reported
elsewhere (28). Gravimetric results predict-
ed from the calibration curves were com-
pared with those actually measured in areas
not used to generate the curves and were
found not to be significantly different. This
suggested that the calibration curves could
be generalized to all areas in the study.
Personal Exposure Estimates. The envi-
ronmental sampling activity was undertak-
en on 432 sample-days (each person sam-
pled for 1 day contributed 1 sample-day).
There were only 13 (3.0%) sample-days
without complete daily measures and only
2 sample-days without even partial data
(0.5%).
Daily versus Short- Term Exposure. The
arithmetic mean of daily exposures in the
comparison group was 0.45 mg/m3 total
dust (0.02 mg/m3 total boron), with virtu-
ally 100% of the daily levels below 1.0
mg/m3 total dust and almost 90% below
0.5 mg/im3. Less than 10% of the 15-min
levels were greater than 1.0 mg/m3. In
contrast, average daily exposure for the
exposed group was 5.72 mg/im3 of total
dust (0.44 mg/m3 total boron), with only
21% of the group showing daily exposures
of less than 1.0 mg/m3 total dust, while
the majority of exposures were between 1.0
and 10.0 mg/m3. A total of 68% of the
exposed subject-days included at least one
15-min interval when exposure exceeded
10.0 mg/m3.
Respiratory Irritation: Preshift
Symptoms. Preshift symptoms reported by
workers surveyed before entry to the work-
place were presumed to be unrelated to
work. Four of the five symptoms were
reported approximately equally by mem-
bers of the comparison and exposed
groups. Only nasal irritation was notably
more prevalent in the comparison group
(11 of 27 vs 25 of 76). Approximately
one-quarter of both groups reported having
a cold on the survey day, and more than
one-third reported having had a cold in the
previous 2 weeks. Although this frequency
of colds appears high, the prevalence was
the same in the two exposure groups.
Respiratory Irritation: Incident
Symptoms. Previous studies of employees
exposed to borate dusts included reports of
nosebleeds as an important finding. In this
study, although subjects were interviewed
regularly about them, no nosebleeds were
reported. Therefore, nosebleeds are not
referred to in any of the tables describing
symptoms. Sneezing is represented only in
the collapsed category, any symptom,
because it was not reported frequently
enough to be evaluated separately.
In contrast to the preshift symptom pat-
tern, the frequency of incident reports was
uniformly higher among the borate-
exposed. The most striking difference was
for nasal irritation, where 23% of the
exposed group reported at least three inci-
dent symptoms, in contrast to none among
the comparison group. When incidence
rates were calculated for each symptom, the
exposed group was almost nine times as
likely to report nasal irritation as the com-
parison group, and seven times as likely to
report breathlessness (Table 7). Among
those exposed, nonsmokers had higher rate
ratios than smokers for nasal (1.3) and eye
(16.8) irritation, and lower rate ratios for
throat irritation (0.9), cough (0.5), and
breathlessness (0.4).
Because dust was measured continuously
over the day, paralleling the collection of
health data, short-term 15-min and daily
exposure levels could be examined in rela-
tion to health outcomes. For these analyses,
risk was expressed as a probability of
response, equal to the proportion of expo-
sure intervals in which a symptom was
reported.
Respiratory Irritation: Exposure-
Responsefor Daily Exposures. When exam-
ined by daily exposure (Table 8), the prob-
ability of nasal irritation increased from
0.01 on days when the daily exposure was
less than 1 mg/m3, to 0.27 when daily
exposures exceeded 15 mg/m3 , almost a
30-fold increase. For all five symptoms, the
probability of response increased with
increasing levels of exposure. These expo-
sure-response trends were statistically sig-
nificant (p<0.05) for all but eye irritation.
When these same relationships were exam-
ined using estimates of daily exposures to
boron in place of total dust the same find-
ings were observed (data not shown).
To adjust for confounding, we included
age, current colds, cigarette smoking, and
dust level as independent variables in logis-
tic models. The results for each symptom
were modeled with subjects included once
for each day of observation (generally four
times). The exposure-response relation-
ships remained present for all five irritant
symptoms (data not shown) with the mag-
nitude of the adjusted risk estimates very
close to the unadjusted risk estimates (29).
To assess the importance of dust type as
well as dust level, a variable for dust type
was added to the model. Due to limitations
in the distribution of type-specific data,
this variable was defined as anhydrous
borax versus other. When this type variable
was included, it was found not to be a sig-
nificant risk factor in any of the models.
Table 7. Acute symptom rate ratios.
Exposed Comparison
Symptom Event Rate Event Rate Rate ratiob
Nasal irritation 152 (1624) a 0.09 6(562) 0.01 8.8
Eye irritation 31(1792) 0.02 2 (615) 0.00 5.2
Throat irritation 56(1689) 0.03 7(609) 0.01 2.9
Cough 89(1697) 0.05 18(594) 0.03 1.7
Breathlessness 20 (1771) 0.01 1(630) 0.00 7.1
a Parentheses contain number of 15 min intervals at risk. b for all rate ratios, p<0.001 based on binomial distribu-
tion (one-sided test).
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Table 8. Probability of response by TWA-6 dust levels. a
Dust concentration, mg/mr3
Symptoms <1 1-4 5-9 10-14 .15c Correlation coefficient
Nasal irritation
Events 7 (877) b 29 (765) 44 (266) 36 (120) 42 (158)
Probability 0.01 0.04 0.17 0.30 0.27 0.964d
Eye irritation
Events 1(958) 4 (858) 7 (275) 11(126) 10 (190)
Probability 0.00 0.01 0.03 0.09 0.05 0.894d
Throat irritation
Events 8 (942) 16 (795) 10 (273) 1(122) 19 (166)
Probability 0.01 0.02 0.04 0.08 0.11 0.980e
Cough
Events 30 (920) 32 (792) 14 (278) 8 (120) 23 (181)
Probability 0.03 0.04 0.05 0.07 0.13 0.929 d
Breathlessness
Events 1(983) 3 (822) 3 (280) 3 (132) 11(184)
Probability 0.01 0.00 0.01 0.02 0.06 0.983
a Dose-response evaluated by weighted least squares method using the midpoint of the dust range for each
group. b Parentheses contain person-hours at risk. c Median (mean) dust level for this category is 23.8 (34.5)
mg/m3. d p<0.05 based on binomial distribution (one-sided test). e p<0.01 based on binomial distribution (one-
sided test).
Table 9. Probability of symptoms of severity .3 by TWA-6 dust levels. a
Dust concentration, mg/rm3
Symptoms <1 1-4 5-9 10-14 15 Correlation coefficient
Nasal irritation
Events 5 (877)b 10 (765) 21(266) 24 (120) 18 (158)
Probability 0.01 0.01 0.08 0.20 0.11 0.859
Eye irritation
Events 0 (958) 3 (858) 6 (275) 9 (126) 3 (190)
Probability 0.00 0.00 0.02 0.07 0.02 0.783
Throat irritation
Events 0 (942) 6 (795) 7 (273) 4 (122) 6 (166)
Probability 0.00 0.00 0.02 0.03 0.04 0.940 c
Cough
Events 4 (920) 7 (792) 4 (278) 3 (120) 5 (181)
Probability 0.00 0.01 0.01 0.03 0.03 0.989 d
Breathlessness
Events 0 (983) 0 (822) 2 (280) 0 (132) 2 (184)
Probability 0.00 0.00 0.01 0.00 0.01 0.018
a Dose response evaluated by weighted least squares method using the midpoint of the dust range for each group.
I ( ) Parentheses contain person-hours at risk. c p<0.05 based on binomial distribution (one-sided test). d p<0.01
based on binomial distribution (one-sided test).
Respiratory Irritation: Exposure-
Response for 15-min Exposures. To exam-
ine how symptoms relate to changes in
short-term exposure levels, each full day
was divided into 15-min intervals. Fifteen-
minute, time-weighted average and symp-
tom status were determined within each
short-term interval. Symptom presence
within an interval was defined by the onset
of an incident symptom. All other at-risk
intervals were associated with the absence
of a symptom. For convenience, a summa-
ry variable (any symptom) representing the
presence of any of the irritant symptoms
was used in these analyses. Examined by
deciles, the probability of an irritant
response in a 15-min interval increased sig-
nificantly from 0.01 in the lowest exposure
category (<0.084 mg/m3) to 0.11 when
the exposure exceeded approximately 10
mg /m 3. Exposure-response associations
having been demonstrated using both daily
and 15-min exposure measures, both daily
and short-term exposure were included in
the same logistic regression model. When
this was done, a strong, linear,
exposure-response trend remained, while
the trend for the daily exposures was rela-
tively flat (29).
Respiratory Irritation: Short-term
Exposure Models. To address the problem
of correlated outcomes when examining
15-min exposures within study subjects,
separate logistic models were estimated for
individual subjects where possible. The 29
subjects who reported a minimum of three
incidents of a symptom during the four
survey days were identified. Dose-
response models were fit to the data for the
25 of these individuals who had complete
exposure data. The exposure-response
parameters estimated in these logistic mod-
els are estimated-odds ratios, (EOR), inter-
preted as an individual's odds of reporting
a symptom given an increase of 1 mg/ m3
in 1 5-min exposure interval.
Ninety percent of the 25 EORs exceed-
ed 1.0. The maximum-likelihood estimate
of the EOR among the subjects with multi-
ple positive responses was 1.02 (95% CI:
1.01-1.04) per unit dust. When these odds
ratios were stratified by smoking, dust type,
duration of employment, recent cold, or
age, none of the effect modifiers signifi-
cantly changed the estimates.
All of the above relationships, using
either daily or 15-min estimates of total
dust exposures were also examined using
estimates of total boron exposures. In every
instance, the results were similar (data not
shown).
Respiratory Irritation: Multiple
Responders. Finally, there was a question as
to whether individuals with multiple-symp-
tom reports were more sensitive or more
highly exposed. The group of subjects with
multiple-symptom reports were younger,
smoked less, and were more likely to have a
current cold or allergy. However, the mul-
tiple responders had substantially higher
average exposures (11.2 vs 3.7 mg/m3).
Respiratory Irritation: Acute Symptom
Severity. The evidence presented suggests
that frequency of irritant events is increased
in a sodium borate-exposed work environ-
ment. The possibility that intensity of the
symptoms reported also increased over
background was also examined. This effort
took advantage of the fact that, for each
symptom reported, the subject was asked
to rate its severity. Subjects responded
without difficulty to this query; and, as
expected, reports of more severe responses
were less frequent.
The severity of symptoms reported by
comparison-group subjects before they
entered the workplace was examined to
suggest background severity levels. The
results showed that background irritant
symptoms were uncommon, and the sever-
ity level was lower than that reported for
symptoms that occurred at work. Among
all comparison subjects without current
colds, the average preshift symptom severi-
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Table 10. Probability of nasal irritation in an hour by TWA-6 dust levels for different severity levels.a
Dust concentration, mg/mr3
Symptoms <1 1-4 5-9 10-14 15 c Correlation coefficient
Any severity
Events 7 (877) b 29(765) 44 (266) 36 (120) 42 (158)
Probability 0.01 0.04 0.17 0.30 .27 0.964 d
.Severity 3
Events 5 (877) 10 (765) 21(266) 24 (120) 18 (158)
Probability 0.01 0.01 0.08 0.20 .11 0.859
.Severity 4
Events 2 (877) 3 (765) 3 (266) 4 (120) 7 (158)
Probability 0.00 0.00 0.01 0.03 .04 0.913
>Severity 5
Events 1(877) 2 (765) 1(266) 0 (120) 3 (158)
Probability 0.00 0.00 0.00 0.00 .02 -0.308
a Dose response evaluated by weighted least squares method using the midpoint of the dust range for each group.
I Parentheses contain person-hours at risk. c p<0.05 based on binomial distribution (one-sided test). d p<0.01
based on binomial distribution (one-sided test).
ty across all symptoms was 1.9, and the
average severity for nasal irritation, the
most common symptom, was 2.2. Those
with current colds reported slightly lower
average severity (2.0) for nasal irritation,
but higher severity for throat irritation (2.0
vs 0.9) and cough (2.3 vs 1.4).
When the frequency distribution of the
severity of responses during the workshift
was described, it was found that, among all
symptoms, 91% were <3 and 96% were
<4. Thus, there was a virtual cap on the
degree of irritation reported in association
with current exposures to sodium borate in
this setting.
Approximately one-third of the total
study time was spent in the lowest exposure
category, < 1 mg / m . Among symptoms
reported in this exposure category there
were virtually none with severity greater
than 2, "very little" (Table 9). At exposures
greater than 1 mg/nm, however, expo-
sure-response associations were seen for
each specific type of symptom of severity
.3. The trends were similar to those seen
when symptom severity was ignored.
When examined in logistic models, it again
was found that confounders did not alter
the significant exposure-response relation-
ships.
Exposure relationships were further
reviewed using a stricter severity criterion.
Severity levels of .4 and .5 were examined
for nasal irritation; the only specific symp-
tom that occurred with sufficient frequency
for such refinement (Table 10). Using
either severity criterion, an increasing risk
with increasing exposure was observed. The
trend for the .4 symptom group was statis-
tically significant.
Discussion
The analysis of the relationship of sodium
borate exposures in the workplace to
chronic effects on pulmonary function
could be examined only by evaluating
annual, functional decline in relation to
exposure between 1981 and 1988. In this
analysis, no association was found between
FEV, and exposure accumulated between
surveys. The expected smoking-related
abnormalities were observed. Thus, it
appears that the 7-year exposure to dust in
the work environment examined is not
associated with long-term health effects. An
effect associated with exposure cumulated
prior to the 1981 survey, although unlike-
ly, has not been ruled out.
Having estimated the likelihood of
response at different exposure levels, it is
possible to consider targets for exposure
control. There are no normative data (inci-
dence or prevalence) on the distribution of
acute irritant symptoms to use as a guide.
The absence of general population rates
makes it necessary to make a judgment
about an acceptable frequency of irritant
symptoms based only on data from this
study.
Were the irritant symptoms considered
to serve as sentinels of chronic, irreversible
changes, it might be required that all symp-
toms of 3+ severity be prevented. The
analysis of the chronic pulmonary function
data, however, suggests that this population
is not developing chronic pulmonary func-
tion decrement attributable to the current
work exposures. Although the analysis does
not provide a definitive answer to whether
the irritant symptoms can be treated only
as short-term reversible events, it is suffi-
ciently convincing to suggest that some fre-
quency of moderate irritation (severity level
3) can be tolerated without undue chronic
sequelae.
The focus on moderate irritation should
be seen in the context of this study's use of
a new symptom severity scale. This scale
has been adapted following extensive use
of similar scales in the evaluation of mus-
culoskeletal and anginal pain. In the
results presented above, the severity scale
has been shown to provide reproducible
and reliable results. In particular, the
reported symptoms occurred with less fre-
quency in the higher severity categories,
but the exposure response relationships
were consistent regardless of severity level
selected as a minimum.
It is important to note, however, that the
severity scale has not yet been used in other
irritant-exposure environments. Thus,
although it has been shown to provide
internally consistent data within this study,
there is limited information on how to
interpret the absolute level of irritation
associated with a moderate response to
sodium borate. Ideally, this scale would
have been applied in the field to study
other known irritants such as sulfuric acid
mist (in a battery plant) or ammonia (in a
chemical manufacturing environment). In
the absence of such data, one is forced to
make the necessary judgments about the
absolute level of severity on the basis of
data collected with a different severity scale
in an experimental, rather than in a field
study. The totality of the evidence suggests
that the current levels of sodium borate
exposures in this plant are generally associ-
ated with no more than moderate irritant
responses.
The definition of an acceptable level of
risk is a difficult and arbitrary one. The
exposure limits necessary for control will
depend on the health risk of interest. For
sensory irritation, in the absence of a
chronic effect, some risk is probably
acceptable. In this circumstance, then, the
selection of an appropriate goal for limits
of exposure to borates is likely to depend in
part on considerations of technical feasibili-
ty and cost.
Lower exposure limits would be required
to achieve longer work-related symptom-
free periods. Using the data available, an
effort was made to estimate the number of
hours or days at different daily exposure
levels during which an irritant symptom
was not probable. The results suggested
that a daily exposure level of 1.0 mg/m3
would permit an exposed worker to experi-
ence one incident symptom per week,
while a daily level of 10.0 mg/m3 would
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make more than one moderate symptom
per day improbable. Examination of
the analogous results for total boron
suggested that the same goal would be
accomplished if daily levels were kept
below 1.0 mg/ m3 of boron.
Differences in the potency of the
three dust types were suggested in
some of the analyses. These differ-
ences, however, were no longer pre-
sent when confounding was taken into
account. In the absence of a specific
analytical method to distinguish dust
type in environmental samples from
the field, type differences cannot be
directly evaluated in field samples.
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APPENDIX
ID Date
Name
U.S. BORAX HEALTH STUDY QUESTIONNAIRE
Shift Day of Subject's Work Week 1 2 3 4 5
Technician
1. Do you have a cold today?
2. Do you have allergic symptoms or asthma today?
3. Have you had a cold in the last two weeks?
4. When did you smoke your last cigarette?
5. Do you usually breath through your: Nc
6. Time_
7. PK Flow Meter Number Readings
No
No
No
ose or Mouth
8. Are your eyes irritated today? (This includes burning painful, tearing or in any other way irritated.)
How recently did this begin?
9. Is your nose irritated today? (This includes runny, stuffy, dry or in any other way irritated.)
How recently did this begin?
10. Have you had a sneezing bout today? (A bout is considered to be 3 or more sneezes in a row)
How recently did this occur?
11. Have you had a recent nosebleed
How recently did this begin?
12. Is your throat irritated today? (This includes sore, dry, scratchy or in any other way irritated.)
How recently did this begin?
13. Are you bothered by coughing today?
Is it dry (D) or with phlegm (P)
How recently did this begin?
14. Is your breathing bothering you today?
Is it due to Chest Tightness (CT), Wheezing (W), Shortness of Breath (SOB), or Other (Other)
How recently did this begin?
D/P
CT I W / SOB / Other
REMIND SUBJECT TO PUSH BUTITONWHEN EXPERIENCING SYMPTOMSAND
THATWE WILLASKTHESE QUESTIONS EVERYHOUR
ID
Date
Time
Pk Flow
Pk Flow
Pk Flow
Pk Flow
1. Score the level of physical exertion
felt by your total body during the last hour ofwork
2. How many cigarettes have you smoked in the last hour
3. When did you smoke your last cigarette?
SINCE THE LAST INTERVIEW Score Onset
2
Time
Pk Flow
Pk Flow
Pk Flow
Pk Flow
4. Have your eyes been irritated?
(This includes burning, painful, tearing, or in any other way irritated.)
How recently did this begin?
5. Has your nose been irritated?
(This includes runny, stuffy, dry, or in any other way irritated.)
How recently did this begin?
3
Time
Pk Flow
Pk Flow
Pk Flow
Pk Flow
Score Onset Score
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Yes
Yes
Yes If yes, when?
Sore Onset
Onset
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6. Have you had a bout of sneezing?
(3 or more sneezes in a row)
How recently did this begin?
7. Have you had a nosebleed?
How recently did this begin?
8. Has your throat been irritated?
(This includes sore, dry, scratchy or in any other way irritated.)
How recently did this begin?
9. Have you been bothered by coughing? -
Is it dry or with phlegm? D/P D/ P
How recently did this begin?
10. Has your breathing bothered you?
Is it due to chest tightness (CT) CT / W /S OB CT / W /S OB
wheezing (W), or shortness Other Other
of breath (SOB)
How recently did this begin?
11. Did you press the marker? No Yes No Yes
How many times?
For what symptom(s)?
RESET TIMER 55 MINUTES
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D/P
CT /W /S OB
Other
No Yes
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